Evidence map›Paper›PMID 40294966›Full record

ArticleCancer biomarkers : section A of Disease markers2025

Exploring lipid metabolism-associated gene biomarkers and their regulatory mechanisms in nasopharyngeal carcinoma.

Yiyi Liu, Yingying Xie, Yong Wang

Abstract read
In one paragraph

Article in Cancer biomarkers : section A of Disease markers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yiyi LiuDepartment of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Yingying XieIntegrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
Yong WangDepartment of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundNasopharyngeal carcinoma (NPC) is a neoplasm that arises from the mucosal lining of the nasopharynx. Recent investigations have underscored that reprogramming of lipid metabolism is a salient metabolic alteration in neoplastic cells. Consequently, identifying lipid metabolism-associated biomarkers in NPC is of paramount importance.MethodsUtilizing transcriptomic datasets, differentially expressed genes (DEGs) were identified from GSE12452, contrasting NPC specimens with normal controls. The Weighted Gene Co-expression Network Analysis (WGCNA) was employed to discern key module genes pertinent to NPC. Lipid metabolism-related differentially expressed genes (LMR-DEGs) were ascertained by intersecting DEGs, key module genes linked to NPC, and lipid metabolism-related genes (LMRGs) using a Venn diagram approach. Subsequently, the MCODE algorithm was applied within the protein-protein interaction (PPI) framework to pinpoint lipid metabolism-centric biomarkers for NPC. The diagnostic potential of these biomarkers was assessed through ROC analysis. In the concluding phase, a 'TF-mRNA-miRNA' interaction network was delineated using Cytoscape.ResultsIn our analysis, a total of 5026 DEGs were discerned when contrasting NPC specimens with normal controls. From this pool, 1835 genes were pinpointed as key module genes pertinent to NPC. Through a Venn diagram approach, 64 LMR-DEGs were isolated. Further analysis led to the identification of six lipid metabolism-centric biomarkers for NPC, namely GALC, SPTLC2, SMPD2, DEGS2, DEGS1, and SMPD3. Notably, these biomarkers demonstrated robust diagnostic efficacy. We found that DEGS1 was negatively correlated with SMPD2 and DEGS2. A comparative expression analysis revealed diminished expression levels of GALC, SPTLC2, SMPD2, DEGS2, and SMPD3 in the NPC cohort relative to the control group. In the terminal phase of our study, the 'TF-mRNA-miRNA' regulatory network was delineated, comprising 309 nodes and 360 interaction pairs.ConclusionIn summary, our investigation identified six lipid metabolism-associated biomarkers (GALC, SPTLC2, SMPD2, DEGS2, DEGS1, and SMPD3) linked to NPC, providing a foundational framework for potential therapeutic interventions for NPC.

Indexed as

Biomarkers, TumorLipid MetabolismNasopharyngeal CarcinomaNasopharyngeal NeoplasmsComputational BiologyGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansProtein Interaction MapsTranscriptomeBiomarkers, Tumorbiomarkersdata analysislipid metabolismnasopharyngeal carcinoma

Identifiers

PMID40294966
PMCPMC12288416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.